These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32461007)
1. Successful therapeutic approach in a patient with elephantiasic pretibial myxedema. Ferreira M; Zacaron LH; Valle AFD; Gamonal ACC An Bras Dermatol; 2020; 95(4):469-472. PubMed ID: 32461007 [TBL] [Abstract][Full Text] [Related]
2. Pre-tibial myxedema: treatment with intralesional corticosteroid. Ramos LO; Mattos PC; Figueredo GL; Maia AA; Romero SA An Bras Dermatol; 2015; 90(3 Suppl 1):143-6. PubMed ID: 26312698 [TBL] [Abstract][Full Text] [Related]
3. A Case of Elephantiasic Pretibial Myxedema Successfully Treated With Intralesional Triamcinolone Acetate. Hathi D; Goswami S; Sengupta N; Baidya A; Gaikwad PM; Das N; Tarenia SS; Oswal R Cureus; 2022 Sep; 14(9):e29234. PubMed ID: 36259012 [TBL] [Abstract][Full Text] [Related]
4. Pretibial myxedema: pathophysiology and treatment options. Fatourechi V Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929 [TBL] [Abstract][Full Text] [Related]
5. Elephantiasic pretibial myxedema in a patient with graves disease that resolved after 131I treatment. Yu H; Jiang X; Pan M; Huang R Clin Nucl Med; 2014 Aug; 39(8):758-9. PubMed ID: 24830877 [TBL] [Abstract][Full Text] [Related]
6. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Fatourechi V; Pajouhi M; Fransway AF Medicine (Baltimore); 1994 Jan; 73(1):1-7. PubMed ID: 8309359 [TBL] [Abstract][Full Text] [Related]
7. [Pretibial myxedema: pathogenetic features and clinical aspects]. Sabanova EA; Fadeyev VV; Potekaev NN; Lvov AN Probl Endokrinol (Mosk); 2019 Jun; 65(2):134-138. PubMed ID: 31271716 [TBL] [Abstract][Full Text] [Related]
8. Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema. Fatourechi V; Garrity JA; Bartley GB; Bergstralh EJ; Gorman CA J Endocrinol Invest; 1993 Jun; 16(6):433-7. PubMed ID: 8370919 [TBL] [Abstract][Full Text] [Related]
15. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Rapoport B; Alsabeh R; Aftergood D; McLachlan SM Thyroid; 2000 Aug; 10(8):685-92. PubMed ID: 11014313 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and treatment of pretibial myxedema. Kriss JP Endocrinol Metab Clin North Am; 1987 Jun; 16(2):409-15. PubMed ID: 3319589 [TBL] [Abstract][Full Text] [Related]
17. Pretibial Myxedema Masquerading as a Venous Leg Ulcer. Herskovitz I; Hughes O; MacQuhae F; Kirsner RS Wounds; 2017 Mar; 29(3):77-79. PubMed ID: 28355140 [TBL] [Abstract][Full Text] [Related]
18. Pretibial myxedema with Graves' disease: a case report and review of Japanese literature. Ishizawa T; Sugiki H; Anzai S; Kondo S J Dermatol; 1998 Apr; 25(4):264-8. PubMed ID: 9609987 [TBL] [Abstract][Full Text] [Related]
19. Elephantiasic pretibial myxedema and cutis verticis gyrata caused by Graves' disease. Bilen H; Atasoy M; Akcay G; Akcay M; Capoglu I; Gursan N; Akbas M Thyroid; 2006 Aug; 16(8):815-6. PubMed ID: 16910888 [No Abstract] [Full Text] [Related]
20. Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis. Heyes C; Nolan R; Leahy M; Gebauer K Australas J Dermatol; 2012 Feb; 53(1):e1-4. PubMed ID: 22309343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]